Med-Surg Final Exam Study Guide

 # Traction and Orthopedic Management

  • Traction is the application of a pulling force to promote and maintain skeletal alignment.

  • Therapeutic Effects (Tx): Primarily used to decrease muscle spasms and pain, realign bone fractures (fx), and correct or prevent deformities.

  • Principles of Traction: Weights are to hang freely at all times and must never be removed. Ropes must remain unobstructed. Traction equipment is placed by a Physical Therapist (PT). Nurses and patients must never remove weights or interfere with the traction setup.

  • Two Main Types of Traction:

  1. Skeletal Traction: Involves screws inserted directly into the bone. Used for longer durations. Weight limit ranges from 2540lb25-40\,lb.

  • Pin Site Care: Assess sites for signs of infection, such as redness streaking up the extremity or purulent drainage at the pin site.

  • Complications: Related primarily to immobility, including atelectasis, pneumonia, constipation, urinary stasis (increasing risk for Urinary Tract Infection [UTI]), infection, and Venous Thromboembolism (VTE).

  1. Skin Traction: Used primarily to decrease muscle spasms. Utilizes a Velcro boot, belt, or halter. Weight limit is significantly lower, between 510lb5-10\,lb.

  • Management (MGMT): Avoid wrinkling or slipping of the traction bandage. Patients should shift positions but must not turn side to side.

  • General Nursing Measures for Traction:

  • Any form of traction requires the use of a trapeze bar to facilitate patient movement.

  • Assess skin for breakdown every 88 hours or once per shift.

  • Assess pin sites: Normal/expected findings include crustiness with serosanguineous drainage and minimal redness.

  • Abnormal findings (not expected): Significant blood, redness extending up the leg, purulent drainage, or a foul odor. If present, clean the wound with saline or chlorhexidine (CHG), culture the wound, and contact the physician for an order.

  • Neurovascular Checks: Evaluate capillary refill, color of toes, ability to wiggle toes, and distal pulses.

  • Pain and General Assessment: Monitor hourly during rounds. Monitor for Deep Vein Thrombosis (DVT); the patient may be prescribed enoxaparin prophylaxis.

Osteoporosis Treatment and Prevention

  • Definition: Characterized by decreased bone mass, deterioration of the bone matrix, and diminished bone strength, leading to notable shrinking.

  • Primary Demographics: Postmenopausal women are most affected.

  • Risk Factors: Rheumatoid Arthritis (RA), sedentary lifestyle, alcohol (ETOH) and tobacco use, corticosteroid use, family history, previous history of fractures, Diabetes Mellitus (DM), inadequate Calcium and Vitamin D intake, low Body Mass Index (BMI), small-framed individuals (particularly Asian and Caucasian), malabsorption issues, and men over the age of 7070.

  • Prevention: Nutrition, appropriate diet, supplements, cessation of smoking and ETOH consumption, weight loss, weight-bearing exercise (such as walking), and Bone Mineral Density (BMD) testing.

  • Education: Increase Calcium and Vitamin D in the diet. Perform 203020-30 minutes of low-weight-bearing exercises, such as walking or swimming.

  • Medication: Bisphosphonates (alendronate, ibandronate, risedronate, zoledronic acid).

  • Mechanism of Action (MOA): Inhibit osteoclasts, leading to decreased bone loss and increased bone mass.

  • Education: Administer on an empty stomach in the morning (AM). The patient must sit upright for 3030 minutes after administration. A dental exam is required prior to beginning therapy. Monitor serum creatinine levels if the medication is administered via IV.

Bone Fractures and Related Complications

  • Definition: A complete or incomplete disruption or continuity of bone structure, defined according to its specific type and extent.

  • Infection Risk: Compound fractures (where the bone opens through the skin) carry a high risk for infection.

  • Compartment Syndrome: A medical emergency involving increased pressure and decreased circulation within a muscle compartment.

  • Pathophysiology: Caused by an increase in compartment volume (edema, bleeding), a decrease in compartment size (restrictive cast), or both.

  • Signs and Symptoms (S/S): Edema, cyanosis, tingling, numbness, paresthesia, and pain that is unrelieved by medications.

  • Treatment (Tx): Fasciotomy.

  • Fat Emboli: A condition where fat travels through the blood to organs, causing blockages. This is most common after trauma or a break in a large bone, such as the femur or pelvis.

  • Signs and Symptoms (S/S): Decreased O2O_2 saturation, dyspnea, tachypnea, tachycardia, chest pain (CP), low-grade fever, crackles, and a petechial rash on the upper torso.

  • Treatment (Tx): Bed rest (BR), oxygen (O2O_2), IV fluids (IVF), possible steroid administration, fracture immobilization, frequent vital sign checks, and raising the Head of Bed (HOB).

Cerebrovascular Accidents (Strokes)

  • Definition: A medical emergency occurring when blood flow to part of the brain is blocked (ischemic) or a blood vessel bursts (hemorrhagic), preventing oxygen and nutrients from reaching brain tissue.

  • Nursing Monitoring: Both types require neurological checks every 11 hour.

  • Ischemic Stroke: Disruption of cerebral blood flow caused by an obstructed vessel.

  • Causes: Large artery thrombosis, small penetrating artery thrombosis, cardiogenic embolus, or cryptogenic causes.

  • Signs and Symptoms (S/S): Numbness/weakness on one side of the face or body, confusion or decreased mental status, difficulty speaking or understanding speech, difficulty walking, dizziness, loss of balance, or a sudden severe headache.

  • Diagnosis (Dx): Any sudden neurological changes must be assessed. Identify one-sided signs and rule out similar pathologies like hypoglycemia.

  • Thrombolytic Therapy (tPa) Candidacy: Determined by the "time of last known well." Treatment must begin within 4.54.5 hours of onset or within 4545 minutes of arrival to the Emergency Department.

  • tPa Specific Requirements: Patient must be 18\ge 18 years old, Platelets > 100,000100,000, no signs of endocarditis, no trauma, brain surgery, or stroke within the last 33 months, no enoxaparin within 2424 hours, PT < 1515 seconds, and INR < 1.71.7.

  • tPa Contraindications: Recent bleeding, recent surgery, or low platelet counts.

  • Diagnostics: CT scan (priority, within 2525 minutes of ED arrival), MRI/MRA, transcranial doppler, Transesophageal Echocardiogram (TEE), EKG, and carotid ultrasound (US).

  • Prevention: Smoking cessation, regular exercise, healthy weight/diet/blood pressure, low-dose aspirin (ASA), and surgical procedures (e.g., ablation for Afib).

  • Hemorrhagic Stroke: Bleeding into brain tissue, ventricles, or the subarachnoid space. Caused by intracerebral rupture of small vessels (related to HTN) or subarachnoid rupture of an aneurysm.

  • Signs and Symptoms (S/S): Severe, sudden headache ("worst headache of life"), N/V, decreased Level of Consciousness (LOC), and seizures.

  • Diagnostics: CT, MRI, and Lumbar Puncture (LP) (only if ICP is not increased and CT is negative).

  • Prevention: Management of Hypertension (HTN), cessation of smoking, and reduction/cessation of alcohol consumption.

  • Complications: Hematoma expansion, rebleeding, cerebral vasospasm, and acute hydrocephalus.

  • Management (MGMT): Bed rest (BR), antiseizure medications, analgesics, antipyretics, Sequential Compression Devices (SCDs), and possible craniotomy.

  • Perfusion Considerations: Frequent neuro checks via the NIH scale, aneurysm precautions, and Deep Vein Thrombosis (DVT) prevention.

  • Medications: Aspirin (ASA), clopidogrel, Heparin, or Warfarin (at provider's discretion).

Intracranial Pressure (ICP) and Brain Tumors

  • Intracranial Pressure: The pressure exerted by brain tissue, blood, and Cerebrospinal Fluid (CSF) inside the cranial vault.

  • Normal Range: 010mmHg0-10\,mmHg.

  • Early Signs of Increased ICP: Disorientation, restlessness, increased respiratory effort, pupil changes (dilation), weakness, and headache.

  • Late Signs of Increased ICP: Changes in Level of Consciousness (LOC), decreased Pulse Rate (PR) and Respiratory Rate (RR), projectile vomiting, hemiplegia, and loss of brain stem reflexes.

  • Diagnostics: CT, MRI, PET, cerebral angiography, and transcranial doppler. Lumbar puncture (LP) must be avoided as it increases ICP further.

  • Management: Avoid coughing, bend at the knees only, and maintain seizure precautions.

  • Medications: Mannitol is used to reduce ICP; dexamethasone is used for swelling.

  • Surgical Intervention: A Burr Hole may be required if swelling does not respond to other interventions.

  • Cushing’s Triad: A late-stage medical emergency signaling imminent brain herniation. Signs include:

  1. Hypertension (with widened pulse pressure)

  2. Bradycardia

  3. Irregular Respiratory Rate (RR)

  • Brain Tumors: Grow as a mass or infiltrate tissue, occupying space in the skull. Effects are caused by inflammation, compression, and infiltration.

  • Primary Tumors: Originate from brain cells (usually glial cells). They progress locally and rarely metastasize. The 55-year survival rate is 33.4%33.4\%.

  • Glioma: Most common intracerebral tumor (types: Astrocytoma, glioblastoma, oligodendroglioma, ependymoma, medulloblastoma).

  • Meningioma: Benign, encapsulated tumor of arachnoid cells; slow-growing; more common in middle-aged women.

  • Acoustic Neuroma: Tumor of the 8th8^{th} cranial nerve; slow-growing. S/S include hearing loss, tinnitus, vertigo, staggering gait, and painful facial sensations.

  • Pituitary Adenomas: Common in older women; rarely malignant. Symptoms relate to pressure and hormonal changes (TSH, T3T_3, T4T_4, cortisol).

  • Secondary Tumors: Twice as common as primary. Metastatic (METS) from lung, breast, GI tract, pancreas, kidneys, or skin.

  • Systemic Symptoms: Increased ICP, headache, visual field disturbances, seizures, behavioral changes, vomiting, and localized symptoms.

  • Medical Management: Options include surgery, radiation, chemotherapy, and anticonvulsant medications (e.g., Keppra, gabapentin, phenytoin).

Seizure Disorders and Epilepsy

  • Seizures: Episodes of abnormal motor, sensory, autonomic, or psychic activity resulting from sudden, excessive discharge from neurons.

  • Manifestations: Muscle rigidity, tonic-clonic activity, loss of consciousness, eyes rolling back, incontinence, tongue chewing, oral secretions, and blood in the mouth.

  • Diagnosis: History and Physical (H&P), EEG, and MRI.

  • Seizure Management (During Event): Protect the patient from injury, time the seizure, turn the patient on their side, and place nothing in the mouth.

  • Seizure Management (Post-Seizure): Priority is airway management. Reorient the client, allow for rest, and initiate fall precautions. Expect weakness, soreness, fatigue, and lethargy.

  • Precautions: Pad side rails and keep suction at the bedside at all times.

  • Epilepsy: Characterized by recurrent, unprovoked seizures; more common in women and older adults. Management includes antiseizure meds, surgery, or vagus nerve stimulation.

  • Medications: Carbamazepine, levetiracetam (Keppra), phenytoin, and valproate. Ativan is used during active seizures.

Dysphagia and Aspiration Precautions

  • Dysphagia: Difficulty swallowing, often seen in conditions like Stroke, Parkinson’s (decreased dopamine), Myasthenia Gravis (Ach junction issues), ALS (motor neuron loss), and Multiple Sclerosis (myelin destruction).

  • Diagnosis: Requires a swallow study. Patients must remain NPO (nothing by mouth) if they fail, requiring aspiration precautions.

  • Management: If a swallow screen is failed on a weekend, the patient remains NPO until evaluated by speech therapy. Fluids and calories are provided via IV.

  • Oral Care: Provide every hour using minimal water.

  • Aspiration Precautions:

  1. Elevate HOB to 9090 degrees.

  2. Use a "chin tuck" technique when swallowing (if not NPO).

  3. Provide small bites; ensure the patient swallowed before the next bite.

  4. Maintain suction at the bedside.

Genitourinary Health: Urinary Tract Infections and Catheterization

  • Urinary Tract Infection (UTI): Can be upper or lower. E. coli is the most common causative agent.

  • Risk Factors: Females, Diabetes Mellitus (DM), pregnancy, neurological disorders, gout, altered states, immunosuppression, and obstruction.

  • Lower UTI (Cystitis, Prostatitis, Urethritis):

  • S/S: Burning, frequency, nocturia, incontinence, pain, hematuria, back/flank/abdominal pain, and confusion in the elderly.

  • Medications: Nitrofurantoin, cephalexin, ciprofloxacin, levofloxacin, ampicillin, amoxicillin, trimethoprim-sulfamethoxazole.

  • Symptom Management: Phenazopyridine (Azo) treats symptoms (not the infection); increase fluids to 23L/day2-3\,L/day; void every 232-3 hours.

  • Upper UTI (Pyelonephritis): Infection of the renal pelvis, tubules, and interstitial tissue.

  • Acute Pyelonephritis: S/S include chills, fever, leukocytosis, bacteriuria, pyuria, low back/flank pain, CVA tenderness, and N/V.

  • Chronic Pyelonephritis: Usually results from recurrent infections. Can lead to kidney scarring, non-function, and CKD. S/S include fatigue, poor appetite, polyuria, and weight loss.

  • Prevention Education: Void before and after sex; wipe front to back; use alternative birth control while on antibiotics (antibiotics make oral birth control ineffective); increase water intake; avoid caffeine; wear cotton underwear; prefer showers over baths.

  • Foley Catheters: Primary cause of CAUTIs (Catheter-Associated Urinary Tract Infections).

  • Purpose: Used for surgery, epidurals, wound management near genitalia, or acute urinary retention.

  • Insertion: Must be a strict sterile procedure. Bag must be kept below the bladder level. The balloon is usually inflated with 10mL10\,mL of sterile water.

  • Sizing: Measured on the French (Fr) scale (1010 to 24Fr24\,Fr).

  • Removal: Fully deflate the balloon before pulling to avoid urethral damage.

  • Perineal Care (Catheter Patients): Start at the meatus (cleanest) and work down to the bifurcation/tubing using a warm, soapy cloth.

  • Females: Clean labia downward (pubis to rectum); use a clean area of the cloth for each stroke.

  • Males: Clean head (glans) in a circular motion starting at the meatus; retract and replace foreskin for uncircumcised patients.

Renal Pathophysiology: Stones, AKI, and CKD

  • Urolithiasis and Nephrolithiasis: Stones in the urinary tract or kidney.

  • S/S: Intense pain, hematuria, N/V, flank pain, abdominal pain.

  • Management: Opioids, NSAIDs, fluids. Surgical options include ESWL (shock waves). Urine must be strained to analyze fragments.

  • Acute Kidney Injury (AKI): Rapid loss of renal function.

  1. Prerenal: Decreased circulation/perfusion to healthy kidneys. Findings: Increased BUN/Creatinine, High USG, Low UOP, Low Sodium (Na+Na^+).

  2. Intrarenal: Actual damage to kidney structures (glomeruli, tubules). Findings: Increased BUN/Creatinine, High Na+Na^+ (Na+Na^+), Low USG.

  3. Postrenal: Obstruction (stones, BPH, tumors). Findings: Increased BUN/Creatinine.

  • Phases of AKI:

  1. Initiation: Insult to start of oliguria.

  2. Oliguria: UOP < 400mL400\,mL in 2424 hours; accumulation of urea, creatinine, uric acid, potassium, and magnesium.

  3. Diuresis: Renal function begins to recover; UOP increases; labs stabilize.

  4. Recovery: Can take months; laboratory values return to normal.

  • Management: Monitor drug levels for toxicity; diuretics, IVF, and high-carb/low-sodium/potassium/phosphorus diet.

  • Chronic Kidney Disease (CKD): Kidney damage or GFR < 60mL/min60\,mL/min for 33 or more months.

  • S/S: Increased creatinine, decreased Calcium (Ca2+Ca^{2+}), increased Phosphorus, anemia (decreased RBCs/H&H), and fluid retention.

  • CKD Stages (by GFR):

  • Stage 1: 90mL/min\ge 90\,mL/min

  • Stage 2: 6089mL/min60-89\,mL/min

  • Stage 3: 3058mL/min30-58\,mL/min

  • Stage 4: 1529mL/min15-29\,mL/min

  • Stage 5: 15mL/min\le 15\,mL/min (ESKD)

  • CKD Medications: ACE Inhibitors (Lisinopril), ARBs (Losartan), Furosemide, Epoetin, Phoslo (phosphate control), Calcitriol (Ca2+Ca^{2+}), and Sodium Bicarbonate.

Gastrointestinal Disorders: IBD and Ostomy Care

  • Crohn’s Disease (Regional Enteritis): Subacute/chronic inflammation through all GI layers (Mouth to Anus).

  • S/S: Fatty stools, diarrhea (520×/day5-20\times/day), RLQ pain, malnutrition, anemia, dehydration, and low Potassium (K+K^+).

  • Ulcerative Colitis: Ulcerative inflammation of the colon and rectum.

  • S/S: Diarrhea (520×/day5-20\times/day) with mucus, blood, and pus; LLQ pain; skin irritation; Low Potassium (K+K^+).

  • Complications: Toxic megacolon, perforation, and increased risk for colon cancer.

  • Nutrition: Low residue, high protein, high calorie. Avoid cold foods, smoking, and milk.

  • Ostomy Care:

  • Stoma Appearance: Should be moist, shiny, and pink/deep red. Oval/round and soft.

  • Stool Consistency: Ascending (fluid), Transverse (liquid), Descending (semi-formed), Sigmoid (formed).

  • Pouch Management: Empty when 1/31/3 to 1/21/2 full. Change bag every 575-7 days. Measure stoma frequently; bag should have a 1/81/8 inch (3mm3\,mm) gap.

  • Dietary Cautions: Avoid gassy, spicy, or odor-producing foods.

Upper GI Pathology and Management

  • H. Pylori: Bacterial infection detected via Urea Breath Test (ingest carbon capsule, test breath in 102010-20 minutes).

  • Prep: Avoid antibiotics/bismuth for 11 month and PPIs for 22 weeks prior to test.

  • Treatment: Triple therapy (1 PPI, 2 Antibiotics) or Quadruple therapy (1 PPI, 2 Antibiotics, Bismuth salt).

  • Hiatal Hernia: Part of the upper stomach moves into the lower thorax. S/S include pyrosis (heartburn), regurgitation, and fullness after eating. Management includes small meals and remaining upright after eating.

  • Pharmacology:

  • NSAIDs: Inhibit COX enzymes. Nonselective (ibuprofen, aspirin) vs Selective (Celebrex). Major side effect is GI ulcers and occult bleeding.

  • H2 Receptor Antagonists: Block histamine to reduce acid (e.g., Carafate/Sucralfate). Take before meals to coat the stomach.

  • Peritonitis: Inflammation of the peritoneum. Signs include a rigid, board-like abdomen and distention. Requires emergency surgery and IV antibiotics.

  • Total Parenteral Nutrition (TPN): Administered via Central Line or PICC. Contains protein, carbs, fats (lipids), etc.

  • Monitoring: Check glucose, weights, and Daily I&O. Use aseptic technique for dressing changes every 77 days. Taper off; if bag runs out, infuse D10D_{10} to prevent hypoglycemia.

  • Nasogastric (NG) Tube: Tip to nose, ear, xiphoid. Confirm with CXR. Turn suction off for 306030-60 minutes after medications.

Cardiovascular Fundamentals, Diagnostics, and Arrhythmias

  • Blood Flow: Vena Cava → RA → Tricuspid → RV → Pulmonary Valve → Pulmonary Artery → Lungs → Pulmonary Vein → LA → Mitral Valve → LV → Aortic Valve → Aorta.

  • Cardiac Conduction/Output:

  • P wave (atrial depolarization), QRS (ventricular depolarization), T wave (ventricular repolarization).

  • CO: HR×SVHR \times SV (36L/min3-6\,L/min).

  • Ejection Fraction: 5575%55-75\%; decreased in Heart Failure.

  • Preload: Stretch at end of diastole. Afterload: Pressure during ejection.

  • Digoxin: Therapeutic level 0.52.00.5-2.0. Toxicity: halos, N/V. Low Potassium (K+K^+) increases risk.

  • Labs: Troponin (<0.1; baseline and 3hr3\,hr recheck), BNP (<100 indicates heart failure), Potassium (3.55.03.5-5.0), Calcium (9.010.59.0-10.5).

  • Coagulation: aPTT (Heparin, medicated 709070-90; Antidote: Protamine Sulfate). PT/INR (Warfarin, medicated INR 2.03.02.0-3.0).

  • Hypertension (BP):

  • Stage 1: 130139/8089130-139/80-89. Stage 2: >140/90.

  • Arrhythmias:

  • Sinus Bradycardia (<60): Treat with Atropine or Dopamine if symptomatic.

  • Sinus Tachycardia (>100): Treat with Beta Blockers, CCBs, or vagal maneuvers.

  • Atrial Fibrillation: "Irregularly irregular," no P waves. Risk for Stroke/Embolus. Treat with Diltiazem, Digoxin, or cardioversion.

  • Ventricular Tachycardia (VT): Repetitive ectopic firing (140180bpm140-180\,bpm). Pulse: cardiovert. No pulse: CPR/Defibrillate.

  • Ventricular Fibrillation (V-fib): Chaos, no pulse. CPR and ASAP Defibrillation.

  • Asystole: Flatline. CPR and Epinephrine. Cannot shock.

Heart Failure and Respiratory Care

  • Right Sided HF: Systemic. S/S: JVD, edema, ascites, liver enlargement.

  • Left Sided HF: Lungs. S/S: Crackles, pink-frothy sputum, dyspnea, orthopnea.

  • HF Education: Daily weights (notify HCP if >1-2\,lbs/day or >3\,lbs/week).

  • Nitroglycerin: Potent vasodilator. Take 11 tablet q5min×3q5\,min \times 3. Call EMS after first dose if not relieved.

  • Respiratory Oxygen Delivery:

  • Nasal Cannula: 16L/min1-6\,L/min; humidify over 4L4\,L.

  • Simple Mask: 58L/min5-8\,L/min.

  • Nonrebreather: 1015L/min10-15\,L/min (gives 100%100\% oxygen).

  • Venturi Mask: 410L/min4-10\,L/min.

  • Arterial Blood Gases (ABGs):

  • Normals: pH (7.357.457.35-7.45), CO2CO_2 (354535-45), HCO3HCO_3 (222622-26).

  • Respiratory Acidosis: Low pH, High CO2CO_2 (COPD, Pneumonia).

  • Respiratory Alkalosis: High pH, Low CO2CO_2 (Hyperventilation).

  • Metabolic Acidosis: Low pH, Low HCO3HCO_3 (DKA, Renal failure).

  • Metabolic Alkalosis: High pH, High HCO3HCO_3 (Vomiting/Suctioning).

  • Lung Conditions:

  • TB: Airborne (N95/Negative pressure). RIPE meds (Rifampin turns urine orange; Pyrazinamide causes gout/high uric acid).

  • Chest Tubes: Suction control should bubble constantly; water seal should only tidale. Never clamp the tube. If it comes out of the patient, apply Vaseline gauze taped on 33 sides.

  • Ventilator Alarms: High pressure (kinks, secretions). Low pressure (disconnection, leak).

Endocrine Disorders

  • Thyroid Disorders:

  • Hyperthyroidism (High and Hot): Graves’ disease. Exophthalmos (artificial tears). High T3/T4T_3/T_4, low TSH.

  • Thyroid Storm (Emergency): Fever >101.3, Tachycardia >130. Give Methimazole/PTU.

  • Hypothyroidism (Low and Slow): Hashimoto’s. Fatigue, weight gain. Give Levothyroxine (take empty stomach, AM).

  • Myxedema Coma: Severe low BP/temp/BG. Emergency.

  • Adrenal Disorders:

  • Cushing’s (Excess Cortisol): Buffalo hump, moon face, truncal obesity. Risk for infection.

  • Addison’s (Low Cortisol): Skin hyperpigmentation, low BP, low sodium, high potassium. Give Hydrocortisone. Elevated legs in recumbent position.

  • Diabetes Insipidus (DI): ADH deficiency. Dilute urine (USG 1.0011.0051.001-1.005). Severe dehydration/thirst. Give Desmopressin.

  • SIADH: Excess ADH. Concentrated urine, hyponatremia. Fluid restriction and seizure precautions (if using 3%3\% saline).